Company: LICN
Filing Date: 2025-01-29
Form Type: 424B5
Source: 0001213900-25-007741
Chunk: 49

Company: Lichen International Ltd
Filing Date: 2025-01-29
Form: 424B5
Chunk 49
---
 offering price of US$0.18 per Class A ordinary share under the securities purchase agreement, dated December 12, 2024; (ii) the issuance and sale of 20,000,000 Class A ordinary shares at the offering price of US$0.14 per Class A ordinary share under the securities purchase agreement, dated December 26, 2024; (iii) the issuance and sale of 25,000,000 Class A ordinary shares at the offering price of US$0.125 per Class A ordinary share under the securities purchase agreement, dated December 30, 2024; and (iv) the issuance of 1,150,000 Class A ordinary shares to certain employees and consultants for their services; |     | US$ |  0.57 |   |
| Net tangible book value dilution per Class A ordinary share to new investors                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |     | US$ | (0.49 | ) |

The foregoing table and discussion is based on
28,750,000 Class A ordinary shares outstanding as of June 30, 2024.

This discussion of dilution, and the table quantifying
it, assumes no exercise of any outstanding options over our Class A ordinary shares.

<div align='center'>S-20

USE OF PROCEEDS</div>

We estimate that the net proceeds from this offering
will be approximately $3,052,000, assuming all Pre-Funded Warrants are exercised and after deducting the placement agent fees and estimated
offering expenses payable by us.

We intend to use the net proceeds from this offering
for working capital and other general corporate purposes.

The amounts and timing of our use of proceeds
will vary depending on a number of factors, including the amount of cash generated or used by our operations, and the rate of growth,
if any, of our business. As a result, we will retain broad discretion in the allocation of the net proceeds of this offering.

<div align='center'>S-21

DESCRIPTION OF SECURITIES WE ARE OFFERING</div>

Lichen China Limited is an exempted company incorporatedunder the Companies Act (Revised) of the Cayman Islands, as amended (the “Cayman Islands
Companies Act”). Pursuant to our amended and restated memorandum and amended and restated articles of association, the authorized
share capital of our company is US$50,000, divided into 1,000,000,000 Class A ordinary shares of a par value